Table 1.
Baseline characteristics.
| Characteristic | Intervention N = 50 |
Control N = 59 |
|---|---|---|
| Age (years), mean (SD) | 78.4 (7.0) | 76.0 (8.0) |
| Sex (women), n (%) | 22 (44.0) | 31 (52.5) |
| BCVA, mean (SD) | 75.6 (11.1) | 76.2 (11.7) |
| Corneal alterations (yes), n (%) | 2 (4.0) | 2 (3.4) |
| AMD status | ||
| Presence of drusen, n (%) | 41 (82.0) | 42 (71.2) |
| Degree of drusen, n (%) | ||
| 1 | 8 (16.0) | 14 (23.7) |
| 2 | 17 (34.0) | 15 (25.4) |
| 3 | 10 (20.0) | 6 (10.2) |
| 4 | 6 (12.0) | 7 (11.9) |
| Missing | 8 (18.0) | 17 (28.8) |
| Pigmentary alterations, n (%) | ||
| Hyperpigmentation | 15 (30.0) | 13 (22.0) |
| Hypo-/hyperpigmentation | 15 (30.0) | 15 (25.4) |
| Hypopigmentation | 3 (6.0) | 5 (8.5) |
| No alterations | 17 (34.0) | 15 (42.4) |
| Geographic atrophy (yes), n (%) | 9 (18.0) | 4 (6.8) |
| LENS status | ||
| Phakic | 30 (60.0) | 37 (62.7) |
| Pseudophakic | 20 (40.0) | 22 (37.3) |
AMD, age-related macular degeneration; BCVA, best-corrected visual acuity; SD, standard deviation.